The Effect of Heparin in Treatment IVF-ET Failure
Launched by YAZD MEDICAL UNIVERSITY · Oct 1, 2010
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
Introduction Embryo transfer failure is defined as ≥3 IVF-embryo transfer failures without pregnancy . In spite of transfer of 3 good quality embryos , just 20-30% of women undergoing IVF will achieve ongoing pregnancy . There are multiple factors that influence IVF-failure.
Autoantibodies may be one of the possible causes of IVF-failure , especially in unexplained and mechanical infertility .
In some studies , antiphospholipid antibody is considered as causative factor on implantation and embryo failure. However some investigators showed that combination therapy with heparin/aspirin in w...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who were 19-35 years old
- • basal FSH \< 10 IU/l
- • body mass index ( BMI ) \< 29 Kg/m²
- • presence of both ovaries
- • three or more pervious IVF-ET failures
- • Top-quality embryos for transfer .
- Exclusion Criteria:
- • Women with polycystic ovary syndrome ( PCOS)
- • endometriosis
- • hydrosalpinx
- • chronic systemic disease( liver, renal , thyroid and thrombocytopenia ) ●Abnormal uterine cavity
- • sever male factor ( azospermia )
- • Patients who had contraindication for unfractionated heparin therapy .
About Yazd Medical University
Yazd Medical University is a prominent academic institution dedicated to advancing medical research and healthcare education. Located in Yazd, Iran, the university plays a critical role in fostering innovative clinical trials aimed at improving patient outcomes and advancing medical knowledge. With a commitment to ethical research practices and collaboration with healthcare professionals, Yazd Medical University actively engages in a wide range of clinical studies across various medical disciplines, contributing to the global body of scientific evidence and enhancing healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yazd, , Iran, Islamic Republic Of
Patients applied
Trial Officials
Mehri Mashayekhy, infertility fellowship
Principal Investigator
Yazd Research and Clinical Centre for Infertility
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials